BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10885678)

  • 1. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model.
    Tsukamoto K; Hirata S; Osada A; Kitamura R; Shimada S
    Pigment Cell Res; 2000 Jun; 13(3):185-9. PubMed ID: 10885678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients.
    Tsukamoto K; Ueda M; Hirata S; Osada A; Kitamura R; Takahashi T; Ichihashi M; Shimada S
    J Dermatol Sci; 2000 Jun; 23(2):126-31. PubMed ID: 10808130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
    Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
    Johansson M; Takasaki A; Lenner L; Arstrand K; Kågedal B
    Melanoma Res; 2002 Jun; 12(3):193-200. PubMed ID: 12140375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction.
    Schittek B; Blaheta HJ; Flörchinger G; Sauer B; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):37-43. PubMed ID: 10417513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.
    Eberle J; Garbe C; Wang N; Orfanos CE
    Pigment Cell Res; 1995 Dec; 8(6):307-13. PubMed ID: 8789739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
    Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients.
    Schittek B; Blaheta HJ; Ellwanger U; Garbe C
    Recent Results Cancer Res; 2001; 158():93-104. PubMed ID: 11092036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of tyrosinase and tyrosinase-related protein 1 sequences from peripheral blood of melanoma patients using reverse transcription-polymerase chain reaction.
    Jin HY; Yamashita T; Minamitsuji Y; Omori F; Jimbow K
    J Dermatol Sci; 2003 Dec; 33(3):169-76. PubMed ID: 14643522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
    Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
    Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
    de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
    Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
    J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the detection of hematogenous micrometastasis in prostate adenocarcinoma and malignant melanoma by RT-PCR.
    Sardi I; Moretti S; Ponchietti R; Arrigucci S; Guazzelli R; Montali E
    Int J Mol Med; 1999 Apr; 3(4):417-9. PubMed ID: 10085416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
    Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.
    Keilholz U; Goldin-Lang P; Bechrakis NE; Max N; Letsch A; Schmittel A; Scheibenbogen C; Heufelder K; Eggermont A; Thiel E
    Clin Cancer Res; 2004 Mar; 10(5):1605-12. PubMed ID: 15014010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
    Brownbridge GG; Gold J; Edward M; MacKie RM
    Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.